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ABSTRACT
Horizontal gene transfer by transposition has been
widely used for transgenesis in prokaryotes.
However, conjugation has been preferred for trans-
fer of large transgenes, despite greater restrictions
of host range. We examine the possibility that trans-
posons can be used to deliver large transgenes to
heterologous hosts. This possibility is particularly
relevant to the expression of large secondary metab-
olite gene clusters in various heterologous hosts.
Recently, we showed that the engineering of large
gene clusters like type I polyketide/nonribosomal
peptide pathways for heterologous expression is no
longer a bottleneck. Here, we apply recombineering
to engineer either the epothilone (epo) or myxochro-
mide S (mchS) gene cluster for transpositional deliv-
ery and expression in heterologous hosts. The 58-kb
epo gene cluster was fully reconstituted from two
clones by stitching. Then, the epo promoter was
exchanged for a promoter active in the heterologous
host, followed by engineering into the MycoMar
transposon. A similar process was applied to the
mchS gene cluster. The engineered gene clusters
were transferred and expressed in the heterologous
hosts Myxococcus xanthus and Pseudomonas
putida. We achieved the largest transposition yet
reported for any system and suggest that delivery
by transposon will become the method of choice
for delivery of large transgenes, particularly not
only for metabolic engineering but also for general
transgenesis in prokaryotes and eukaryotes.
INTRODUCTION
Transposable elements were discovered by Barbara
McClintock in maize (1) and subsequently in the vast
majority of cells from prokaryotes to eukaryotes (2–4).
The simplest transposon is a segment of DNA ﬂanked
by sequences present as inverted repeats that are recog-
nized by a corresponding transposase, which catalyzes
transposition via a cut and paste mechanism. DNA trans-
posons have been applied for gene delivery to insert trans-
genes at new locations in the genome (5). Unlike
homologous recombination, transposition only requires
the inverted repeats and does not require homology
between the transposon and its target site (6,7).
Transposon technology is now widely used for several
applications, including in vitro mutagenesis for DNA
sequencing or protein structural–functional studies, or
in vivo insertional mutagenesis for functional gene analysis
and gene transfer.
Unlike the severe limitations of size for transgenes
in retroviral vectors, size limits for transposon vectors
remain poorly deﬁned. Only a few studies have examined
the issue (8–12). These studies all report reductions of
transpositional insertion frequencies with increasing size,
with suggestions that eﬃciency might be dramatically or
even exponentially sensitive to insert size. In vitro, trans-
position of DNA as large as 86kb has been reported (13),
but to our knowledge, there is no report in any system of
successful transposition of a transgene larger than 20kb
into a heterologous host.
In many bacterial strains, transferring and integrating
large sized DNA molecules into the chromosome is diﬃ-
cult because both homologous and random recombination
eﬃciencies are low. Therefore, transposition technology
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unless inherent size limitations restrict its utility.
The mariner family of transposable elements was ﬁrst
discovered in Drosophila mauritiana (2) and is named
because it has spread to virtually all eukaryotic and
some prokaryotic organisms. Mariner transposons are
usually small elements around 1300-bp long with 27bp
inverted terminal repeats, which contain a single open
reading frame encoding a transposase of 345 amino
acids (14). The mariner family is most closely related
to the Tc1 family of transposons found in nematodes,
Drosophila and ﬁsh (14,15). The MycoMar transposable
element (16), a mariner transposon, has been frequently
used in Gram-negative hosts for genetic modiﬁcation.
DNA cloning and mutagenesis are important technolo-
gies for molecular biology and the biosciences. Con-
ventional DNA engineering tools like restriction
enzymes and DNA ligases have been successfully used
for several decades (17,18). However, these technologies
encounter diﬃculties for engineering and mutating DNA
molecules >15–20kb. We pioneered a technique for DNA
manipulation, now called recombineering or Red/ET
recombination, which overcomes these obstacles (19–25).
Recombineering is mediated through homologous recom-
bination, which allows the exchange of genetic informa-
tion between two DNA molecules in a precise, speciﬁc and
faithful manner. These qualities are optimal for DNA
engineering regardless of size. Furthermore, recombineer-
ing technology requires only short regions of sequence
identity ( 40–50bp) for eﬃcient homologous recombina-
tion. These homology sequences are short enough to be
easily integrated into synthetic oligonucleotide (oligo)
primers for PCR reactions (19–25).
Bioactive natural products are often synthesized by
pathways of enzymes encoded in large gene clusters,
such as the genes encoding megasynthetases of the poly-
ketide synthase (PKS) and the nonribosomal peptide
synthetase (NRPS) types. These pathways present enor-
mous potential for combinatorial biosynthesis (26–28).
However, complete PKS/NRPS gene clusters are often
>30kb. Modifying these large gene clusters by using con-
ventional DNA engineering technology is diﬃcult and
time-consuming. Because recombineering has no size and
site limit, it is an ideal technique for engineering large
DNA molecules like these gene clusters. The myxochro-
mide (mchS,  30kb) and myxothiazol (mta,  60kb) gene
clusters from the myxobacterium Stigmatella aurantiaca
have been engineered by using recombineering for heterol-
ogous expression in Pseudomonas putida and Myxococcus
xanthus (29–31). These gene clusters were introduced into
the chromosome of the heterologous host by conjugation
or transformation and homologous recombination
(29,31,32). Here, we extend and improve this metabolic
engineering technology by showing that transposons are
more eﬃcient than other methods for achieving transgenic
delivery, even for large gene clusters.
We describe engineering of two gene clusters for trans-
position in this article, the 30-kb myxochromide S (mchS)
gene cluster (29–31) and the  60kb epothilone gene clus-
ter (33–35). Epothilones are produced by the myxobacter-
ium Sorangium cellulosum (33) and the gene cluster (epo)
has been introduced into Streptomyces coelicolor (35),
M. xanthus (36) and Escherichia coli (37). In each case,
the cluster was introduced in at least two smaller pieces
using laborious protocols based on DNA transformation.
Here, the full-length epo gene cluster was ﬁrst stitched
together into a single plasmid and then the promoter
was exchanged, followed by addition of a transpositional
cassette, conjugation origin and selection markers.
Afterwards, the full size gene clusters with all the neces-
sary components were introduced into heterologous hosts
for expression.
Because many successful drugs come from prokaryotic
secondary metabolites encoded in large operons, the com-
bination of recombineering and transpositional delivery
into heterologous hosts opens a new window for metabolic
engineering, drug development and production.
MATERIALS AND METHODS
Bacterial strains andculturing conditions
All recombineering was performed in E. coli strain
GB2005, which is a derivative of DH10B, using Luria
broth (LB) medium and antibiotics (kanamycin [Km],
15mg/ml; ampicillin [Amp], 100mg/ml; blasticidin S
[BSD], 50mg/ml; gentamycin [Genta], 6mg/ml; zeocin
[Zeo], 15mg/ml and tetracycline [Tet], 5mg/ml). Heterolo-
gous hosts for PKS/NRPS gene cluster expression were
M. xanthus DK1622 (38) and P. putida KT2440 (25). Myx-
ococcus xanthus DK1622 was grown at 328C in CTT
medium (1% casitone, 8mM MgSo4, 10mM Tris-HCl,
pH 7.6, and 1mM potassium phosphate, pH 7.6) (38)
with or without Km (50mg/ml) before or after introduction
of epothilone (epo) gene cluster. Pseudomonas putida
KT2440 or FG2005 (30) was maintained in LB medium
and the recombinants were selected in Pseudomonas mini-
mum medium (PMM) medium with Km (50mg/ml) (29) or
Genta (10mg/ml) after conjugation.
Recombineering
Recombineering, also called Red/ET recombination, was
described previously (19–25,39). GB2005 cells harboring
pSC101-BAD-gbaA with Tet resistance (39) were used for
preparing recombineering proﬁcient competent cells.
Electrocompetent cells were electroporated with 0.3mgo f
a linear DNA fragment (modiﬁcation cassette), which was
obtained by PCR. The selection of recombinants was car-
ried out depending on the selection marker in the cassette.
PCRs were performed with Phusion polymerase (New
England Biolabs, GmbH, Frankfurt am Main,
Germany) according to the manufacturer’s protocol.
Engineering of the mchSgene cluster
The pUC-mchS was derived from a SuperCos 1 vector
that contains most of the mchS pathway. The missing
gene at the 30 end was added, along with a cassette for
conjugation as described (29). Two rounds of recombi-
neering were used for engineering of the pUC-mchS plas-
mid. We used our recently developed technology
named triple recombination for the ﬁrst round.
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inverted repeat; Tps, MycoMar transposase gene) and the
ampicillin resistance gene (0.3mg each in 2ml) were
cotransformed into recombineering proﬁcient competent
cells in which the pUC-mchS is resident. Recombinants
were selected on LB plates containing 100mg/ml of
Amp. For second round recombineering, the IR-Tn5-kan
cassette (Tn5, Tn5 promoter; kan, kanamycin resistance
gene) ﬂanked with homology arms was generated by PCR.
The PCR product (0.3mg) were used for recombineering
and the recombinants were selected on LB plates with
15mg/ml of Km (Figure 1).
Oligos used for IR-Tps-amp insertion are listed below.
Sequence as homologous arm for recombineering is in
lowercase.
irtase3
50 tcaaatccgctcccggcggatttgtcctactcaggagaTTATTCAA
CATAGTTCCCTTC 30 irtase5 (the underlined sequence
is the IR)
50 tccacaggtcattcaagcgcgcgctggggaaggcaggcaggatgggatc
tgatcAGACCGGGGACTTATCAGCCAACCTGTTAT
GTGG 30
amptase3
50 tccagactttacgaaacacggaaaccgaagaccattcatgttgttgctcag
gtcgcagaTTACCAATGCTTAATCAGTGAG 30
amptase5
50 tcgttataatcgttgtatcgctcttgaagggaactatgttgaataaTCT
CCTGAGTAGGACAAATCCG 30
Oligos used for insertion of IR-Tn5-kan cassette were
tn5neoIR3 and tn5neoIR5.
tn5neoIR3 (the underlined sequence contains the ribo-
somal binding site)
50 tggacactaccccacggctagaaacttcggtcaatacagaatttcctatca
tAATCTGTACCTCCTTAAGTCAGAAGAACTCGTCAAGAA
G3 0
tn5neoIR5 (the underlined sequence is the IR)
50 tgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagA
CAGGTTGGCTGATAAGTCCCCGGTCTTCACGCT
GCCGCAAGCACTCAG 30
For expression of mchS in P. putida,a noriT-tetR-tet
cassette was re-inserted into the backbone to be able to
conjugate the gene cluster into P. putida. A PCR product
of the oriT-tetR-tet cassette with homology arms was
inserted into the pTps-mchS between amp and pUC
origin by recombineering (Figure 1).
Oligos used for insertion of oriT-tetR-tet cassette were
oriTOtps3 and oriTOtps5.
oriTOtps3
50 cacggaaaccgaagaccattcatgttgttgctcaggtcgcagaTCAG
CGATCGGCTCGTTGCCCTG 30
oriTOtps5
50 tagacagatcgctgagataggtgcctcactgattaagcattggtaATA
ATGGTTTCTTAGAGCTTACGGCCAG 30
Engineering the epo genecluster
The cosmid library of S. cellulosum ce90 genomic DNA
(40) was screened by using probes generated by PCR.
The primers epoA-check5 (50-TTACGCGCGCA
TCTTTCCTGAG-30) and epoA-check3 (50-TTTCAGCA
CGATTTCTTGGGAG-30) were used to amplify a frag-
ment in epoA. The primers epoK-check5 (50-TATGAC
electroporation
transposition
M. xanthus mch
M. xanthus::mchS
(i)
(ii)
(iii)
(iv)
(v)
(vi)
mchC amp oriT tet cm Pm mchA
IR Tps pUC tetR trpE xylS
IR Tn5-kan
IR Tps
amp
mchC kan oriT tet cm Pm mchA
zeo pUC tetR trpE xylS
(viii)
(vii)
mchC amp tetR IR mchA
IR Tps oriT tet pUC Tn5-kan
transposition
mch P. putida
P. putida::mchS
conjugation
mchC amp IR mchA
IR Tps pUC Tn5-kan
oriT tetR tet
Figure 1. Diagram of myxochromide S gene cluster engineering.
In the ﬁrst step, the inverted repeat and MycoMar transposase gene
(IR-Tps, i) plus amp (ii) were inserted into the mchS expression plasmid
(iii) backbone by triple recombination to delete zeo and kan (iv). The
MycoMar Tps plus IR fragment (i) was generated by PCR from the
original MycoMar transposon (12). In the second step, the oriT-tet-
trpE-cm-xylS section (13) in the backbone was replaced with a right IR
and Tn5-kan cassette (v), which included a ribosomal binding site for the
mchS gene cluster, by selection for kanamycin resistance. In the third step,
the modiﬁed plasmid (vi) was electroporated into M. xanthus and kana-
mycin-resistant colonies were selected. To introduce the gene cluster
into P. putida, an additional cassette containing oriT and the tetracy-
cline-resistant gene (oriT-tetR-tet, vii) was inserted between amp and
the pUC origin (pUC) to form the ﬁnal construct (viii) for P. putida
expression. See remarks in the Materials and Methods section.
PAGE 3 OF 14 Nucleic Acids Research, 2008, Vol. 36,No. 17 e113ACAGGAGCAAGCGAATC-30) and epoK-check3 (50-T
AAGGTAGATCGTGGTATCGGTG-30) were used to
amplify a fragment in epoK. The cosmid end sequencing
results show that pSuperCos-epo35 contains the part of
epoC and full of epoD till the end of epoK, and pSuperCos-
epo14 contains epoA to epoC and the part of epoD.
To stitch the epothilone gene cluster together
(Figure 3A), epoD-K genes were subcloned into a p15A-
Cm minimum vector that was generated by using linear-
ized pACYC184 (41) as template to form p15A-epo35.
The zeocin (zeo) resistance gene with a 50 end homology
arm to p15A-cm-epo35 and a 30 end homology arm to a
region in front of epoA in pSuperCos-epo14 was ampliﬁed
by PCR. pSuperCos-epo14 was digested with ScaI to
release a 26-kb fragment which carries the short homology
arm to the zeo PCR product and a long homology arm
( 9.45kb) to p15A-cm-epo35. After mixing the zeo PCR
product with the digested pSuperCos-epo14, the mixture
was transformed into a recombineering proﬁcient host
containing p15A-cm-epo35. The stitched full-length
epothilone gene cluster was selected by zeo and analyzed
by restriction digestion (Figure 3B). The junction regions
of the stitched cluster were veriﬁed by sequencing.
To generate the conjugation/transposition cassette, by
recombineering the blasticidin S-resistant gene (bsd) was
inserted between the MycoMar transposase gene (Tps)
and oriT in pMycoMar-hyg plasmid (32) to form the
IR-Tps-bsd-oriT cassette (Figure 4A). The PCR product
of this cassette with homology arms to the stitched
p15A-epo-cm-zeo plasmid was used to replace the chlor-
amphenicol (cm) gene in the backbone to form p15A-epo-
IR-Tps-bsd-oriT-zeo. A PCR fragment containing the
second IR plus Tn5-kan plus a ribosomal binding site
(rbs) after the kan stop codon ﬂanked with two homology
arms to the p15A-epo-IR-Tps-bsd-oriT-zeo was used to
replace zeo to form the ﬁnal epothilone expression plasmid
p15A-epo-IR-Tps-bsd-oriT-IR-kan for expressing in
M. xanthus (Figure 4A). Since the Tn5 promoter is weak
in P. putida (data not shown), after two rounds of recom-
bineering the Pm promoter (toluic acid inducible) (29) plus
its regulator gene (xylS) and the gentamycin-resistant gene
(genta) were used to replace Tn5-kan to form p15A-epo-
IR-Tps-bsd-oriT-IR-genta-xylS-Pm which is the ﬁnal
expression plasmid for P. putida expression. All of the
engineering was done by recombineering.
To create the IR-Tps-bsd-oriT cassette, BSD PCR was
generated by using oligonucleotides bsdINtps3 50 tgacgc
cgttggatacaccaaggaaagtctacacgaaccctttggcaTTTAAATC
GGATCTGATCAGCACGTGTTG 30 and bsdINtps5 50
ttggaaggtcgttataatcgttgtatcgctcttgaagggaactatgttgaataaTT
TAAATTAGCCCTCCCACACATAACCAG 30.
A minimum linear vector containing p15A ori and cm
for subcloning of epo gene cluster from pSuperCos-epo35
was generated by using oligo 15epo35a 50 tgcgatcaactgc
gtcagatcgtcctgcgacatctcctcgACTAGTACAACTTATAT
CGTATGGGGCTG 30 and 15epo35b 50 cgaacctcattccct-
catgatacagctcgcgcgcgggtgcACTAGTTAACCGTTTTTA
TCAGGCTCTGG 30.
One pair of oligos epo-tri-a and epo-tri-b was used for
the generation of zeo. epo-tri-a is 50 tatctcttcaaatgtagcacct-
gaagtcagccccatacgatataagttgtAGCACGTGTTGACAAT
TAATC 30 and epo-tri-b is 50 gggccgcgagatcggcggcggcgaa
ggagtTCAGTCCTGCTCCTCGGCCAC 30.
The bsd gene for pMycoMar-hyg was generated by
using oligonucleotides 50-tcgttataatcgttgtatcgctcttgaaggga
actatgttgaataatttaaaTTAGCCCTCCCACACATAAC-30
and 50-tgacgccgttggatacaccaaggaaagtctacacgaaccctttggca
TTTAAATCGGATCTGATCAGCACGTGTTG-30.
The oligonucleotides used for IR-Tps-bsd-oriT PCR
were 50-tagctcgcgggggtatcgcttcccgaacctcattccctcatgatacag
AGACCGGGGACTTATCAGCCAACCTGTTATGTG
GC-30 (the underlined sequence is the IR) and 50-tccggcgg
tgcttttgccgttacgcaccaccccgtcagtagctgaacaggagggacctagag
TCGATCTTCGCCAGCAGGGCGAG-30. IR-tn5-kan
fragment was generated by using oligonucleotides 50-tctct
tcaaatgtagcacctgaagtcagccccatacgatataagttgtactagtACAG
GTTGGCTGATAAGTCCCCGGTCTTCACGCTGCC
GCAAGCACTCAGGG-30 (the underlined sequence is
the IR) and 50-cgacgatcgcaatcggatcttcggctgcgcgctcgatggg
acgatccgccatAATCTGTACCTCCTTAAGTCAGAA
GAACTCGTCAAGAAGG-30 (the underlined sequence
contains the ribosomal binding site). Cm-xylS-Pm frag-
ment was generated by using oligonucleotides 50-tcgccgct
cccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgaTCCT
GGTGTCCCTGTTGATACCG-30 and 50-tcgcaatcggatct
tcggctgcgcgctcgatgggacgatccgccatGTTCGTGACCTCCA
TTATTATTGTTTCTGTTGC-30. The gentamycin gene
was generated by using oligonucleotides 50-tgccgcaagcact
cagggcgcaagggctgctaaaggaagcggaacacgtagaaagccagtccgcT
GAAGGCACGAACCCAGTTGAC-30 and 50-tgggttggca
tcgcccggctttcttagacactctccaagctctgaaatagcgttttacaaaTCG
GCTTGAACGAATTGTTAGGTG-30.
Electroporation of M.xanthus
The engineered gene clusters were introduced into the
chromosome of M. xanthus DK1622 by electroporation.
Brieﬂy, M. xanthus cells from 1.7ml of overnight culture
with OD600 0.6 were collected and electrocompetent cells
were prepared after two times washing with ice-cold water.
Fifty microliter of the cell suspension in cold water were
mixed with 3mg of DNA and electroporated (Electro-
porator 2500, Eppendorf AG, Hamburg, Germany) at
1200V using 0.2cm cuvette. After electroporation, 1.2ml
of CTT medium were used to resuspend cells, and the cells
were incubated at 328C in a 2ml Eppendorf tube with a
hole punched in the lid on a Thermomixer (Eppendorf) at
11000 r.p.m. for 6h. One milliliter of 1.5% CTT agar
solution at 428C was added to the tube and the cells
were plated in soft agar for selection on CTT agar plates
supplemented with Km (50mg/ml). Km-resistant colonies
appeared after 6 days and were checked by colony PCR
as follows. Part of a single colony was washed once in 1ml
of H2O and resuspended in 100mlo fH 2O. Then, 2mlo f
the resulting suspension was used as a PCR template using
Taq polymerase (Invitrogen GmbH, Karlsruhe, Germany)
according to the manufacturer’s protocol. The myxochro-
mide-speciﬁc primers used to check the integration of
mchS gene cluster into the M. xanthus chromosome
were the same as used in previous study (29). Epothi-
lone-speciﬁc primers were designed to detect epoA,
epoC and epoK of the gene cluster to verify the integration
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mosome. For ampliﬁcation of epoA fragment, epoA-
check5 (50-TTACGCGCGCATCTTTCCTGAG-30) and
epoA-check3 (50-TTTCAGCACGATTTCTTGGGAG-
30) were used; for ampliﬁcation of epoC fragment, epoC-
check5 (50-GACTGCCGAGAGAAAATCGAG-30) and
epoC-check3 (50-ATCTGCATAGATGTCCGTCTTG-30)
were used; and for ampliﬁcation of epoK fragment, epoK-
check5 (50-TATGACACAGGAGCAAGCGAATC-30)
and epoK-check3 (50-TAAGGTAGATCGTGGTATCG
GTG-30) were used.
Conjugation of P. putida
Engineered gene cluster expression constructs were intro-
duced into the chromosome of P. putida FG2005 for epo
and P. putida KT2440 for mchS (30) by triparental con-
jugation, as described previously (42). The selection of
integrants was carried out on PMM agar plates containing
Km (50mg/ml) for P. putida KT2440 for mchS and Genta
(10mg/ml) for P. putida FG2005. The obtained clones were
tested by colony PCR (Taq-polymerase, Invitrogen) with
the speciﬁc primers as used for checking the mchS and epo
containing M. xanthus clones above.
Integration site detection
Single-primer (semi-random) PCR has been described
previously (43,44). It is used to detect the integration site
of transposition. Primer epo-Po-1 or epo-Po-2 was
employed to amplify a PCR product containing a
known region and the ﬂanking unknown region of the
epothilone gene cluster.
epo-Po-1
50 TAGCCGAATAGCCTCTCCACC 30
epo-Po-2
50 GCGGGGCATCGATCAAGAAAG 30
Primer epo-Pn-1 or epo-Pn-2 is for sequencing.
epo-Pn-1
50 TCTTGATCCCCTGCGCCATC 30
epo-Pn-2
50 CTCCAGGCCAGACGTGTTTG 30
The PCR was performed using an Eppendorf
MasterCycler using either oligo epo-Po-1 or epo-Po-2.
After 30min at 948C for denaturation, 20 cycles of 10min
at 948C, 10min at 558C and 1min at 728C were run. Next
30 cycles with low stringency, programmed as 10min at
948C, 10min at 408C and 1min at 728C were employed.
Finally, 30 cycles of 10min at 948C, 10min at 558C and
1min at 728C were used for further ampliﬁcation.
Analysis ofmyxochromide Sproduction in M. xanthus
The M. xanthus DK1622::pTpS-mchS mutant containing
the mch S biosynthetic gene cluster was incubated in
250ml shaking ﬂasks containing 50ml CTT medium (casi-
tone 10g/l, 1M Tris pH 7.6 10ml/l, 1M K2HPO4 pH 7.6
1ml/l, 0.8M MgSO4 10ml/l) amended with the adsorber
resin XAD-16 (1%) and with Km (50mg/ml). The culture
was inoculated with 500ml of a well-grown preculture and
incubated for 4 days at 308C on a rotary shaker (160 rpm).
The cell mass and the Amberlite XAD-16 adsorber resin
from the culture broth were harvested by centrifugation
and extracted with acetone/methanol (1:1), respectively.
The extract was evaporated, redissolved in 1ml of metha-
nol and 5ml of the concentrated extract was analyzed
using a DIONEX HPLC system with a diode-array detec-
tor (PDA-100). Chromatographic separation was carried
out on a RP column (Nucleodur C18, 125 2mm, 3mm
partical size; Macherey & Nagel, GmbH & Co. KG,
Du ¨ ren, Germany) equipped with a precolumn
(8 3mm/5mm). The mobile phase gradient (solvent A:
water+0.1% formic acid and solvent B: acetoni-
trile+0.1% formic acid) was linear from 50% B at
2min to 60% B at 22min and from 60% B at 22min to
95% B at 26min, followed by 3min with 95% B at ﬂow
rate of 0.4ml/min; detection was carried out at 400nm.
Myxochromides S were identiﬁed by comparison to the
retention times and UV spectra of authentic reference
standards. For quantitative analysis peak integration
was carried out utilizing the Chromeleon software pack-
age (Version 6.50). A calibration curve was established
from serial dilutions of myxochromides S1 and S3. Sam-
ples under investigation were diluted as required to ﬁt the
dynamic range of the method.
Analysisof Myxochromide Sproduction in P. putida
The P. putida strain containing the myxochromide S bio-
synthetic gene cluster (P. putida::pTps-mchS-oriT) was
incubated in 250ml shaking ﬂasks containing 50ml LB
medium amended with Km (50mg/ml). The culture was
inoculated with an overnight culture (1:100) and incubated
for 2 days at 308C on a rotary shaker (160rpm). The cells
were harvested by centrifugation and extracted with acet-
one. The extract was evaporated and redissolved in 500ml
of methanol and 5ml of the concentrated extract was ana-
lyzed by high-pressure liquid chromatography–mass spec-
trometry (HPLC–MS); an Agilent 1100 series solvent
delivery system coupled to Bruker HCTplus ion trap
mass spectrometer was used. Chromatographic separation
was carried out on an RP column Nucleodur C18 (125 by
2mm, 3mm particle size; Macherey and Nagel) equipped
with a precolumn C18 (8 3mm, 5mm). The mobile-phase
gradient (solvent A: water+0.1% formic acid and solvent
B: acetonitrile+0.1% formic acid) was linear from 50% B
at 2min to 60% B at 22min and from 60% B at 22min to
95%Bat26min,followedby3minwith95%Batﬂowrate
of 0.4ml/min. Detection was carried out in positive ioniza-
tionmode.MyxochromideS1wasidentiﬁedbycomparison
to the retention time and the MS
2 pattern of the authentic
reference standard (m/z [M+H]
+=723). For quantita-
tive analysis, samples were separated on a gradient linear
from 57% B at 2min to 90% B at 7.50min, followed by
1.50min at 90% B. Quantitation was carried out in manual
MS
2 mode. Ions of m/z [M+H]
+=723 were collected
and subjected to fragmentation. Peak integration of the
characteristic fragment ions m/z 322 was carried out utiliz-
ing the Bruker Quant-Analysis v1.6 software package.
A calibration curve was established from serial dilutions
of myxochromide S1 down to 1mg/ml.
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Myxococcus xanthus strains containing the gene cluster
were inoculated from an overnight culture and incubated
in 300-ml ﬂasks containing 50ml CTT medium supple-
mented with Km (50mg/ml) and containing 2% XAD 16
adsorber resin (Rohm und Haas, Frankfurt, Germany) for
5 days at 308C (200rpm). The cells and the resin were
harvested by centrifugation and extracted with acetone
and methanol. Solvents were removed in vacuo, and the
residue was dissolved in 1ml methanol. An aliquot of 5ml
was analyzed by HPLC–MS as described previously (31).
Detection was carried out in positive ionization mode.
Epothilones were identiﬁed by comparison to the reten-
tion time and the MS
2 pattern of the authentic reference
standards.
The P. putida FG2005 clones carrying the epo gene
cluster were cultured in LB medium with 10mg/ml genta-
mycin. Induction of the culture with toluic acid was
performed according to previous publications (29).
Compound extraction and analysis were performed simi-
lar as described above for extraction of epothilones from
M. xanthus.
RESULTS
Engineering themchS gene cluster
The myxochromide S biosynthetic gene cluster is 29.6-kb
long including three large genes. For the work here, the
starting construct was the one which we previously used
for heterologous expression in P. putida (29). As illus-
trated in Figure 1, we used triple recombination to insert
the MycoMar transposase, right IR and the ampicillin
resistance gene downstream of mchS gene cluster
(Figure 1). The development of triple recombination for
DNA engineering will be described elsewhere (J.F., A.F.S.
and Y.Z.; manuscript in preparation). Brieﬂy, we used two
PCR products, with a 40bp overlapping region to each
other and one homology arm each to the targeting molec-
ule. Further recombineering was performed to insert the
left IR plus Tn5-kan in front of the mchS gene cluster. The
Tn5 promoter will drive both the kan gene and the mchS
gene cluster expression (Figure 1). The ﬁnal construct was
veriﬁed by sequencing the regions generated by PCR, as
well as the recombination junctions. The MycoMar trans-
posase gene sequence is identical to the sequences in the
Gene Bank (DQ236098 or AY672108). The left IR is 50
ACAGGTTGGCTGATAAGTCCCCGGTCT 30 and the
right IR sequence is 50 AGACCGGGGACTTATCAGC
CAACCTGT 30.
The engineered mchS gene cluster in the transposon
(pTps-mchS) for M. xanthus expression was used to elec-
troporate P. putida KT2440 directly without success.
Therefore, an oriT cassette was integrated into the con-
struct to be able to conjugate the gene cluster into
P. putida (Figure 1). As discussed below, after conjugation
of this construct into P. putida, successful transposition
took place.
Production ofmyxochromides after introduction of
the mchSpathwayfrom S. aurantiaca into M. xanthus
and P. putida
Myxochromide S compounds are characterized by their
yellow–orange color and are easily observed in culture.
Colonies from pTps-mchS transformation were reddish
(Figure 2A) and the liquid cultures are reddish as well
(data not shown). A methanol extract from M. xanthus
DK1622::pTps-mchS was analyzed with HPLC and
HPLC/MS for the production of myxochromides
S. Myxochromides S1–3, known from S. aurantica, could
be identiﬁed in extracts of the M. xanthus mutant strains
via HPLC [Figure 2B, peaks 1 (S1), 2 (S2), 3 (S3)], which
could also be veriﬁed via HPLC/MS analysis (data not
shown). Due to the high production of myxochromides
Si nM. xanthus ( 500mg/l), minor myxochromide S deri-
vatives could also be detected (peaks marked with an
asterix, Figure 2B).
After integration of an additional oriT cassette, the
transposon was conjugated and subsequently also inte-
grated into P. putida (Figure 1). By using tri-parental con-
jugation, we detected more than 10
6 Km-resistant colonies.
Twelve of these were analyzed by PCR and found to be
correct genotypically. These clones were cultured and
compounds were extracted from cells. The engineered
mchS gene cluster was indeed expressed in P. putida but
the production level was found to be low ( 100mg/ml;
data not shown).
Stitching of theepothilone gene cluster and engineering
fortransposition
Cosmid pSuperCos-epo35 is 53kb in size and contains
45.3kb of the epothilone gene cluster, whereas cosmid
pSuperCos-epo14 is 42-kb large and contains 34.5kb of
the epothilone gene cluster. They share a 24-kb overlap.
The stitching procedure to reconstitute the entire cluster is
diagrammed in Figure 3A, and was based on two rounds
of recombineering and the generation of two intermediates
(zeo PCR product and linear epoA-D fragment). The ﬁrst
recombineering step to subclone the epoD-K region into
the p15A-cm minimal vector was accomplished with high
eﬃciency and >5 10
3cm-resistant colonies were
obtained. When 24 colonies were analyzed by restriction
digestion, 21 of 24 were correct (the other 3 were found to
be pACYC without inserts; data not shown). In the
second step, a zeo PCR product was used in a triple
recombineering exercise to bring the 26-kb long linear
epoA-D fragment into p15A-cm-epo35. To facilitate this
step and reduce the recombineering background due to
carryover of the PCR template, the zeocin resistance
gene was ampliﬁed from an R6Kg plasmid, because repli-
cation of R6Kg plasmid needs the   protein encoded
by the pir gene, however the pir gene is not present in
the E. coli strain GB2005. We expected the second
round of recombineering to be diﬃcult because: (i) long
linear fragments, here 26kb, only ineﬃciently enter E. coli
cells; (ii) after entry into E. coli, the identical repeats
in the epoA-D region can promote intramolecular rearran-
gements; and (iii) in triple recombination, three molecules
(p15A-cm-epo35, the zeo PCR product and the 26-kb long
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cell for productive recombination. After triple recombina-
tion, we found 100 colonies on zeocin plates. By checking
with restriction digestion, we found that the majority of
the recombinants (21 out of 24 clones) contained zeo plus
only a short part of the epoA-D fragment because of intra-
molecular rearrangement. However, the other three were
correct recombinants. After retransforming the correct
plasmids to separate them from the unrecombined original
plasmid, one plasmid was rechecked by NcoI digestion
(Figure 3B) and the junction regions were veriﬁed by
sequencing.
The transpositional cassette, IR-Tps-bsd-oriT, was con-
structed by inserting the bsd gene between the Tps and
oriT in pMycoMar-hyg to form pMycoMar-bsd-hyg.
A PCR product of IR-Tps-bsd-oriT (2.6kb) ﬂanked with
homology arms was generated using high-ﬁdelity Phusion
polymerase and linearized pMycoMar-bsd-hyg as the tem-
plate (Figure 4A). After electroporation into E. coli con-
taining the stitched epo cluster, recombinants were selected
by plating on BSD plus Zeo plates and incubated at 308C
overnight. This replaced the chloramphenicol (cm) resis-
tance gene in p15A-cm-zeo-epo with the IR-Tps-bsd-oriT
cassette to form the intermediate p15A-epo-IR-Tps-bsd-
oriT-zeo. In the next round of recombineering, an IR-Tn5-
kan-rbs PCR product ﬂanked with homology arms was
used to remove zeo and also place a ribosomal binding
site in front of epoA to generate p15A-epo-IR-Tps-bsd-
oriT-IR-kan. These ﬁnal recombinants were selected by
plating on BSD plus Km plates. More than 50 colonies
were pooled from the plate and plasmid DNA was pre-
pared and retransformed into empty E. coli cells to sepa-
rate unrecombined and recombined plasmids. Three pure
recombinants were veriﬁed by sequencing of IR-Tps-bsd-
oriT cassette and IR-Tn5-kan-rbs-epoA region and two
were found without any mutation in the functional
regions.
Production of epothilonesafter introduction of theepo
pathwayinto M. xanthus
Plasmid DNA from veriﬁed engineered clones was used
to transform M. xanthus (Figure 4A). After entering
M. xanthus, transposase expression will integrate the engi-
neered epo cluster randomly into the M. xanthus genome.
Stable integrants were selected on Km plates. For p15A-
epo-IR-Tps-bsd-oriT-IR-kan, which is 60.5kb in size, we
obtained 90 colonies after 6–8 days incubation at 308C.
For pTps-oriT-mchS, which is 35kb in size, we obtained
>500 Km-resistant colonies using the same protocol
(Table 2). Hence, as expected, transposition eﬃciency is
reduced for larger transposons. Nevertheless, we report
transposition of a 60-kb transgene at a readily obtained
frequency that was well beyond the rate required for suc-
cessful transgenesis.
Twelve Km-resistant colonies were checked by colony
PCR reactions to verify full integration of the biosynthetic
gene cluster. Ten were correct and eight of these were
fermented for compound extraction. All eight produced
epothilones B, C and D and detectable amounts of epothi-
lone A (Figure 4B and C). Hence, we show that multiple
C
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NH O
myxochromides S 
R = CH3 (S1), C2H5 (S2) or CH=CHCH3 (S3) 
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B
(a)
(b)
0
Figure 2. Detection of myxochromide S compounds in M. xanthus.
(A) The color of M. xanthus colonies transformed with the mchS gene
cluster is shown. Colonies from M. xanthus::pTps-mchS (1–7) and
M. xanthus::pTps-lacZ (LacZ) were picked and replated on a kanamycin
plate. The photo was taken after 2 days incubation. (B) the chemical
structures of myxochromides S1–3.( C) HPLC proﬁles from extracts
of the M. xanthus::pTpS-mchS mutant strain (a) in comparison to
M. xanthus wild-type (b); diode array detection at 400nm. Numbers cor-
respond to substances as follows: 1, Myxochromide S1; 2, Myxochromide
S2; 3, Myxochromide S3. Peaks marked with an asterisk are assumed to be
Myxochromide S derivatives as well.
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cluster, followed by transpositional integration, resulted in
functional expression.
In contrast to myxochromide formation, epothilone
production was low (average  100mg/l), but the diﬀerence
between each clones was small (data not shown) indicating
that the integration site in the chromosome had little eﬀect
on epo gene cluster expression driven by the Tn5
promoter.
Conjugation and transpositionto introduce the
epopathway into P. putida
The epo gene cluster is derived from myxobacterium
S. cellulosum and it is not surprising that it can be used
to produce epothilone compounds in M. xanthus. To test
the gene cluster expression in a diﬀerent bacterial species,
P. putida was chosen. Wild-type P. putida has successfully
been used for mchS gene cluster expression (29) and
genetically engineered P. putida FG2005 producing
methylmalonyl-CoA (mm-CoA) has been applied for myx-
othiazol gene cluster expression (30). During the P. putida
engineering process, the Tn5 promoter was used to drive
the lacZ gene expression and it was found to be weak in
this strain (unpublished data). Therefore, the construct
used for M. xanthus is most likely not suitable for epo
gene cluster expression in P. putida. When introducing
the mutase-epimerase-meaB genes for production
of methylmalonyl-CoA from S. cellulosum So ce56 into
P. putida, the Km resistance gene has been used for selec-
tion (30). Thus, a new selection marker gene had to be
used for introducing the epo gene cluster into FG2005.
Analyzing natural resistances of P. putida, we found this
strain to be sensitive to gentamycin at 5mg/ml. To test if
a gentamycin resistance gene (genta, aacC1) functions
in P. putida, genta was inserted into the RK2 ori-based
plasmid pJB866 (45) to build pJB866-genta which con-
ferred gentamycin resistance after transformation of
P. putida.
We next aimed to generate a derivative of the epo gene
cluster for expression in P. putida by inserting the Pm
promoter. To achieve this, a cm-xylS-Pm cassette with
homology arms was ampliﬁed from the template plasmid
pJB866-cm (in which cm was inserted behind the Pm
regulator gene xylS in pJB866). The cm-xylS-Pm PCR
product was inserted in front of the epoA gene in p15A-
epo-IR-Tps-bsd-oriT-IR-kan to form the construct p15A-
epo-IR-Tps-bsd-oriT-IR-kan-cm-xylS-Pm (Figure 5).
recombination
subclone
epoD
ScaI
epoE
overlap 9448 bp
epoF
epoK cm p15A
p15A-epo35
44248bp
a
ScaI digestion
ScaI
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pUC amp
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b
epoA epoB epoC epoD′
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b
5′ 5′
zeo
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a b
9448 bp
epoE
zeo p15A
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p
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M: DNAmarker
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1865bp
1153bp
pSuperCos-epo35
AB
7272bp
Figure 3. Engineering diagram for stitching of the epothilone gene cluster. pSuperCos-epo35 and pSuperCos-epo14 were the starting clones, which
include an overlap in the epoD gene. pSuperCos-epo35 was retroﬁtted with the p15A origin and the chloramphenicol resistance gene from
pACYC184 by subcloning to remove the pSuperCos backbone, introduce the short homology arm ‘(A)’ and create p15A-epo35. pSuperCos-
epo14 was digested with ScaI and the epoA-D genes were recombined into p15A-epo35 by triple recombination using a bridging zeo.I n( B), the
NcoI digest reveals the correct product. (the NcoI sites in p15A-epo35 and p15A-epo are shown in Appendix 1 in Supplementary Material).
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to remove Tn5-kan and cm to form the ﬁnal epo
construct p15A-epo-IR-Tps-bsd-oriT-IR-genta-xylS-Pm
for P. putida FG2005 expression.
Sequencing veriﬁed the correctness of the construct,
which was conjugated into FG2005 by tri-parental conju-
gation and stable integrants of epo clones were selected
by gentamycin on PMM plates. Conjugation/transposi-
tion is an eﬃcient process and more than 10
4 Genta-
resistant colonies were obtained. The conjugation/trans-
position eﬃciency of this large sized DNA molecule was
found to be similar to small sized DNA molecules like
mchS gene cluster (data not shown). The same primers
used for colony PCR in M. xanthus were used again to
verify the P. putida clones. Veriﬁed clones were induced by
toluic acid during fermentation and compounds were
extracted from culture medium and cells. No epothilone
could be detected in any of these extracts.
Verification ofgene integration by transposition
To verify thatthe plasmid, p15A-epo-IR-Tps-bsd-oriT-IR-
kan, had integrated into P. putida FG2005 by transposi-
tion, we used single primer PCR (43,44) to determine the
sequenceoftheintegrationsiteofthreeclones(Table1).All
threesitesincludeaduplicatedTAdinucleotideattheinser-
tion site, which is diagnostic of transposition. The three
insertion sites are in the 619th gene, 4266th gene and
5136th genes of P. putida KT2440 (GenBank AE015451).
The ﬂanking sequences of the insertion sites in the three
genes were found to be exactly the right IR plus the left
IR. This validates the successful transposition by the
designed construct with the mariner transposable element.
epo
IR Tps bsd oriT IR Tn5-kan
epoK p15A cm xyl pm epoA
cm xyl pm
IR Tps bsd oriT IR
epoK p15A gent xyl pm epoA
gent
IR Tps bsd oriT IR Tn5-kan
epoK p15A epoA
P. putida
P. putida::epo
conjugation
transposition
(i)
(ii)
(v)
(iv)
(iii)
Figure 5. Engineering of epo gene cluster for P. putida FG2005 expression. PCR product of Cm resistance gene, Pm promoter and its regulator xylS
gene (i) were inserted in front of epoA in the epo gene cluster (ii) to drive expression of the whole epo gene cluster (iii). PCR product of gentamycin
resistance gene (iv) was used to replace Tn5-kan and cm to generate the ﬁnal construct (v) for P. putida FG2005 expression. The veriﬁed ﬁnal
construct was integrated into the FG2005 genome by conjugation and transposition.
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in M. xanthus
Myxococcus xanthus can be transformed by electropora-
tion and transgenes can be integrated into the chromo-
some via homologous recombination. However, the
eﬃciency of integration of large DNA molecules into the
chromosome is low and candidate clones must be screened
carefully to exclude spontaneous mutants which give Km
resistance. Transposition has been used frequently in myx-
obacteria for insertional mutagenesis and the eﬃciency of
stable integration is much higher than homologous recom-
bination (32).
To compare homologous and transpositional integra-
tion in M. xanthus, we used the validated epo and mchS
expression constructs described above in a comparison
with a homologous integration plasmid pOPB18 (total
size 6.7kb containing a 1.7-kb homology region to the
myxovirescin gene cluster in M. xanthus) (31) and a
small transposition plasmid, pTps-lacZ (derivative of
pMycoMar-hyg, containing a 5.5-kb lacZ-kan-R6K cas-
sette inside of IRs). Table 2 shows the number of trans-
formants which were obtained. The numbers are averages
of three transformations done for each plasmid on a molar
basis. Interestingly, we found that the colonies which
appeared on Km plates before 7 days were all correct but
the colonies which appeared after 8 days were sponta-
neous mutants containing no inserts.
pTps-mchS is 35kb in size and the integration fragment
inside of the two IRs is 31kb large. p15A-epo-IR-Tps-bsd-
oriT-IR-kan is 61kb in size and the transposable element
is 57.5kb. Although the large constructs have lower eﬃ-
ciency than small integration fragments (pTps-lacZ), their
integration process is much more eﬃcient than the small
homologous integration plasmid (pOPB18), regardless of
the fact that, in general, the transformation eﬃciency
drops dramatically with increasing size of the DNA (46).
DISCUSSION
Transposons forlarge transgenes andmetabolic engineering
Transposons have been employed as eﬃcient mutagens in
both prokaryotes and eukaryotes. They have also been
used as vectors for eﬃcient and stable introduction of
transgenes into recipient genomes. These applications
have been invariably based on relatively small (<10kb)
transposons. As far as we can determine, the potential
to use transposons as vectors for the integration of large
transgenes has not been explored in any system, whether
prokaryotic or eukaryotic. Although we do observe
decreased eﬃciencies with increased transgene size as
expected, transposon-mediated transgenesis with a 57.5-
kb transgene was more eﬃcient than transgenesis via
homologous recombination using a small construct.
Hence, we suggest that transposition could be a valuable
tool for delivery of large transgenes in various prokaryotic
and eukaryotic systems. The size of the transgene is partic-
ularly relevant for metabolic engineering where the new
challenges lie with manipulation of complete pathways,
not just single gene products.
For prokaryotes, there are two limiting factors for inte-
grating transgenes into the host chromosome by conventi-
onal methods: transformation eﬃciency and homologous
recombination eﬃciency. Many bacterial hosts, especially
those which are known as prominent secondary metabolite
producers (e.g. actinomycetes, cyanobacteria, myxobac-
teria), appear to possess limited capacity for homologous
recombination. Consequently, chromosomal integration
appears diﬃcult even with small transgenes.
Transposition in vivo is an active process and often thou-
sands of colonies can be obtained after each transforma-
tion with small constructs. To evaluate transposition for
delivery of large transgenes in M. xanthus, we compared a
small ( 6kb), medium ( 31kb) and a large sized insert
(over 57kb) in transpositional constructs. As expected,
the transformation and transpositional integration eﬃcien-
cies depended on the size of the insert. When a medium size
construct with a 1-kb homology arm for homologous inte-
gration was used to transform M. xanthus, very few (<10)
colonies appeared. But more than 500 colonies were
obtained when the same construct was introduced by
transposition (Table 2). With the larger epo gene cluster
(57.5kb), transposition delivered fewer colonies. However,
this number (90 clones) is still considerably larger than our
experience with integration via homologous recombination
Table 2. Transformation eﬃciency in M. xanthus
p15A-epo-IR-Tps-
bsd-oriT-IR-kan
pTps-mchS pTps-lacZ pOPB18
Size (kb) 61 35 15.6 6.7
Colonies 90 635 1020 9
Table 1. Integration site of epothilone in P. putida KT2440
Clone Insertion locus and orientation
(IS = IR-tn5-kan-epoA-epoB-
epoC-epoD-epoE-epoF-epoK-IR)
Genome
location
Name of the gene
1 AGTTGCTCGGCCACCCGCTCAAGTA(IS)
TACAAAGTCATCGACACCGAAGGCA
725684 Branched-chain amino
acid ABC transporter,
periplasmic amino acid-binding protein
2 TGTCGCGCAACGAAATCGGCAATTA (IS)
TACCTTGGCCTGGCGGTAGAAACCG
4850861 Transcriptional regulator Anr
3 CCTGGTACTGGGCCTGGGCTACGTA (IS)
TATTCTTCTTCAACCTGAACGGCAAC
5860472 ABC transporter, permease protein
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tional delivery can be a useful tool for stable transgenesis,
which is particularly relevant for large constructs.
Aspects ofsecondary metabolite expression
inheterologous hosts
Other observations from this report are discussed below.
(i) The production of mchS gene cluster in M. xanthus
was higher than 500mg/l and the total myxochromide
compounds in some isolates was >1g/l. Interestingly,
the same (Tn5) promoter-driven mchS gene cluster in
P. putida produced only 100mg/l of myxochromides
at 308C (and no compound was detected at 168C).
However, mchS production in P. putida from the
Pm promoter reached 40mg/l at 168C (29).
Together with other observations (unpublished
data), we conclude that the Tn5 promoter in
P. putida is weak, or under unexpected repression.
(ii) More than 80% of the clones carrying the epo or
mchS gene clusters were correct as ascertained by
PCR. Together with other data presented here,
this indicates that the transformation/transposi-
tional integration strategy delivers a high proportion
of full length, unmutated, large transgenes into het-
erologous hosts like M. xanthus. The transposition
is mediated by a transient expression of MycoMar
transposase gene. Therefore, after integration, the
insert is stable in the chromosome. Since the type
I PKS/NRPS gene clusters are composed by many
repetitive sequences, we have tested the clones car-
rying the gene clusters by Southern blot and PCR.
There was no rearrangement in six tested clones
(data not shown). In our experience with various
strains, we have not seen production or growth
changes over many generations. We conclude that
transpositional integration of type I PKS/NRPS
gene clusters into heterologous host is stable, with
few rearrangements or position eﬀects.
(iii) Electroporation of large transgenes into P. putida is
diﬃcult. Small plasmids can be easily electroporated
into P. putida but plasmids >30kb construct can
hardly be transformed (data not shown). Conjugation
has been applied in P. putida to deliver large chromo-
somal sections (47,48). The combination of conjuga-
tion and transposition with small constructs has been
reported some time ago (49–51). We integrated the
 60kb epo gene cluster into the P. putida genome
with similar eﬃciencies compared to a small construct
and the majority of the recombinants were correct as
conﬁrmed by PCR tests. Hence, previous size pro-
blems with P. putida transformation appear to have
been solved.
(iv) The epothilone gene cluster was engineered and intro-
duced into the heterologous hosts, M. xanthus and
P.putida.Epothiloneproductionwasloworundetect-
able, respectively. There are several possible reasons.
First, the Tn5 promoter may be too weak to drive
substantial expression in these heterologous
hosts. Second, culture conditions like temperature or
media components may not be optimal. Third, in
P. putida FG2005, endogenous mm-CoA levels may
be the limiting factor for epothilone production.
Advanced recombineering formetabolic engineering
Recombineering is a DNA engineering methodology based
on homologous recombination in E. coli (19–25).
Conventional DNA engineering technology relies on
DNA restriction and ligation. However, it is very hard to
ﬁnd convenient restriction sites in the large DNA regions
which encode secondary metabolite pathways. DNA liga-
tion relies on puriﬁed linear DNA molecules, which are
diﬃcult to obtain in time-consuming processes that are
ineﬃcient especially for large sizes. Because there are no
size limits for recombineering, and in vitro DNA handling
steps are eliminated or reduced, it is well suited for the
challenges presented by secondary metabolite pathways.
In addition to several routine applications, here we pres-
ent an advanced recombineering exercise involving DNA
stitching by triple recombination. DNA stitching mediated
by recombineering has been previously applied for bacter-
ial artiﬁcial chromosome (BAC) stitching (52,53) and a
similar approach has been applied in yeast for more than
a decade (54–56). Here, we were working with cosmids, so
the genomic DNA insert average is 40kb in size. Because
most type I PKS/NRPS gene clusters are rarely contained
within one cosmid and usually present in two or three, a
convenient method for stitching cosmids together will be
useful. We developed a strategy to stitch using a selection
marker (zeo) as a bridge to bring two large molecules,
which share a region of sequence overlap at one end,
together in a triple recombination step. Triple recombina-
tion presents two advantages for stitching. First, it avoids
PCR ampliﬁcation of the cloned DNA, so it can be applied
to large molecules and without fear of mutagenesis in func-
tional regions. Second, it represents a simple and easy way
to introduce the second region of homology. The ﬁrst
region is the overlap between the two parental cosmids.
However for productive recombination, another region is
required. This can be easily introduced into the reaction via
the oligonucleotides used to PCR the zeocin cassette.
Because the PCR product is small and encodes the zeocin
resistance gene, the disadvantages of PCR mutagenesis do
not compromise the recombination product.
Triple recombination for stitching presents the further
advantage of speed and simplicity because it can save sev-
eral DNA engineering steps. However, it is much less eﬃ-
cient than standard recombineering applications based on
recombination of a single linear DNA substrate into a
circular target. Furthermore, we observed a high unspeci-
ﬁc recombination rate when stitching the epo gene cluster
due to intramolecular rearrangement.
This work further extends our technology platform for
the engineering of full-length gene clusters for heterolo-
gous expression. This platform includes DNA stitching
by recombineering, transpositional cassette insertion, con-
jugation cassette insertion and inducible promoter inser-
tion. Several technologies including recombineering,
electro-transformation, conjugation and transposition
have been explored for this platform. We aim to make
further technical advances as well as to venture into the
e113 Nucleic Acids Research, 2008, Vol. 36, No. 17 PAGE 12 OF14unknown territory represented by silent secondary metab-
olite clusters discovered in genome sequencing and meta-
genomic programs.
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